Private Wealth Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Buy
17,470
+390
+2% +$22.7K 0.11% 122
2025
Q4
$921K Hold
17,080
0.1% 129
2025
Q3
$770K Sell
17,080
-5,280
-24% -$247K 0.09% 130
2025
Q2
$1.04M Sell
22,360
-255
-1% -$12.5K 0.14% 112
2025
Q1
$1.38M Buy
+22,615
New +$1.32M 0.2% 87

Other funds holding BMY

Private Wealth Asset Management's BMY Position: Q1 2026 in Review

Private Wealth Asset Management increased its Bristol-Myers Squibb (BMY) stake by 2.3% in Q1 2026, buying an estimated $22.7K and bringing the position to 17,470 shares worth $1.06M. The position accounts for 0.11% of the portfolio, ranked #122.

Private Wealth Asset Management first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.38M in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Private Wealth Asset Management held 17,470 shares of Bristol-Myers Squibb worth $1.06M as of Q1 2026.
  • Private Wealth Asset Management bought 390 Bristol-Myers Squibb shares in Q1 2026, an estimated $22.7K.
  • Bristol-Myers Squibb made up 0.11% of Private Wealth Asset Management's portfolio in Q1 2026, its #122 holding.
  • Private Wealth Asset Management first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
  • Private Wealth Asset Management's Bristol-Myers Squibb position peaked at $1.38M in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Private Wealth Asset Management's 13F filing for Q1 2026, filed 6 May 2026.